Boditech Med Inc. (206640.KQ)

KRW 16490.0

(-1.55%)

Net Income Summary of Boditech Med Inc.

Boditech Med Inc.'s latest annual net income in 2023 was 25.94 Billion KRW , up 7.43% from previous year.
Boditech Med Inc.'s latest quarterly net income in 2024 Q2 was 9.67 Billion KRW , up 45.44% from previous quarter.
Boditech Med Inc. reported an annual net income of 24.15 Billion KRW in 2022, down -45.56% from previous year.
Boditech Med Inc. reported an annual net income of 44.36 Billion KRW in 2021, down -2.47% from previous year.
Boditech Med Inc. reported a quarterly net income of 9.67 Billion KRW for 2024 Q2, up 45.44% from previous quarter.
Boditech Med Inc. reported a quarterly net income of 6.27 Billion KRW for 2023 Q2, up 13.11% from previous quarter.

Annual Net Income Chart of Boditech Med Inc. (2023 - 2015)

Historical Annual Net Income of Boditech Med Inc. (2023 - 2015)

Year	Net Income	Net Income Growth
2023	25.94 Billion KRW	7.43%
2022	24.15 Billion KRW	-45.56%
2021	44.36 Billion KRW	-2.47%
2020	45.48 Billion KRW	290.47%
2019	11.64 Billion KRW	789.07%
2018	-1.69 Billion KRW	21.28%
2017	-2.14 Billion KRW	-117.02%
2016	12.62 Billion KRW	740.56%
2015	-1.97 Billion KRW	0.0%

Year	Net Income	Net Income Growth
2024 Q1	6.64 Billion KRW	36.26%
2024 Q2	9.67 Billion KRW	45.44%
2023 Q2	6.27 Billion KRW	13.11%
2023 FY	25.94 Billion KRW	7.43%
2023 Q3	9.23 Billion KRW	47.12%
2023 Q1	5.55 Billion KRW	15.55%
2023 Q4	4.87 Billion KRW	-47.17%
2022 FY	24.15 Billion KRW	-45.56%
2022 Q1	8.58 Billion KRW	50.78%
2022 Q2	4.78 Billion KRW	-44.24%
2022 Q3	5.97 Billion KRW	24.82%
2022 Q4	4.8 Billion KRW	-19.6%
2021 FY	44.36 Billion KRW	-2.47%
2021 Q3	14.27 Billion KRW	10.62%
2021 Q1	11.49 Billion KRW	-33.85%
2021 Q2	12.9 Billion KRW	12.27%
2021 Q4	5.69 Billion KRW	-60.11%
2020 Q2	11.27 Billion KRW	334.53%
2020 FY	45.48 Billion KRW	290.47%
2020 Q4	17.37 Billion KRW	21.98%
2020 Q3	14.24 Billion KRW	26.33%
2020 Q1	2.59 Billion KRW	-17.88%
2019 Q4	3.15 Billion KRW	-25.43%
2019 FY	11.64 Billion KRW	789.07%
2019 Q1	2.9 Billion KRW	165.35%
2019 Q2	1.35 Billion KRW	-53.49%
2019 Q3	4.23 Billion KRW	213.87%
2018 FY	-1.69 Billion KRW	21.28%
2018 Q4	-4.44 Billion KRW	-562.18%
2018 Q2	1.43 Billion KRW	297.88%
2018 Q3	961.18 Million KRW	-32.83%
2018 Q1	359.63 Million KRW	105.74%
2017 Q2	1.75 Billion KRW	-16.04%
2017 Q1	2.09 Billion KRW	-8.5%
2017 FY	-2.14 Billion KRW	-117.02%
2017 Q4	-6.26 Billion KRW	-2468.4%
2017 Q3	264.36 Million KRW	-84.95%
2016 Q2	3.7 Billion KRW	18.09%
2016 Q4	2.28 Billion KRW	-34.49%
2016 Q1	3.13 Billion KRW	207.93%
2016 Q3	3.49 Billion KRW	-5.79%
2016 FY	12.62 Billion KRW	740.56%
2015 Q4	-2.9 Billion KRW	21.02%
2015 FY	-1.97 Billion KRW	0.0%
2015 Q3	-3.68 Billion KRW	-228.64%
2015 Q1	1.75 Billion KRW	0.0%
2015 Q2	2.86 Billion KRW	62.89%

Peer Net Income Comparison of Boditech Med Inc.

Name	Net Income	Net Income Difference
HLB Pharmaceutical Co., Ltd	-19.42 Billion KRW	233.557%
CMG Pharmaceutical Co., Ltd.	6.45 Billion KRW	-301.94%
Celltrion Pharm, Inc.	21.26 Billion KRW	-22.016%
Huons Global Co., Ltd.	38.38 Billion KRW	32.402%
DongKook Pharmaceutical Co., Ltd.	47.17 Billion KRW	44.999%
Enzychem Lifesciences Corporation	-9.32 Billion KRW	378.206%
Humedix Co., Ltd.	24.82 Billion KRW	-4.536%
EuBiologics Co., Ltd.	-13.87 Billion KRW	286.949%
FutureChem Co.,Ltd	-6.7 Billion KRW	486.747%
Huons Co., Ltd.	50.47 Billion KRW	48.593%
BNC Korea Co., Ltd.	25.68 Billion KRW	-1.014%
AptaBio Therapeutics Inc.	-12.06 Billion KRW	315.117%